Imaging of adrenocortical metastases with [11C]metomidate

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 8, 2006, Pages 974-

  Mitterhauser, Markus ^a,b   Dobrozemsky, Georg ^c   Zettinig, Georg ^a   Wadsak, Wolfgang ^a   Vierhapper, Heinrich ^a   Dudczak, Robert ^a   Kletter, Kurt ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

METOMIDATE C 11; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADRENAL CANCER; ADULT; ARTICLE; CASE REPORT; GALLBLADDER; HUMAN; IMAGING; METASTASIS; PERITONEUM; POSITRON EMISSION TOMOGRAPHY; RECURRENT DISEASE; STOMACH;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ETOMIDATE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMAGE ENHANCEMENT; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS;

EID: 33746392010     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0103-9     Document Type: Article

References (4)

1. Becherer A, Vierhapper H, Pötzi C, Karanikas G, Kurtaran A, Schmaljohann J, et al. FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 2001;16:289-95
2. 11C-metomidate. J Nucl Med 2000;41:275-82
3. 18F] FDG for PET imaging of metastases from adrenocortical origin [abstract]. Eur J Nucl Med Mol Imaging 2002; 29(Suppl 1): S372
4. 11C-metomidate. Eur J Nucl Med Mol Imaging 2004;31:1224-30